Entera Bio (ENTX) Other Non-Current Assets (2020 - 2026)
Entera Bio (ENTX) recorded quarterly Other Non-Current Assets of $90000.0 in Q1 2026, up 1400.0% on a QoQ basis from $6000.0 in Q4 2025, and down 2.17% year-over-year from $92000.0 in Q1 2025.
Entera Bio (ENTX) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Entera Bio has disclosed Other Non-Current Assets across 7 years of filings, most recently posting $90000.0 for Q1 2026.
- Quarterly Other Non-Current Assets fell 2.17% year-over-year to $90000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $90000.0 (down 2.17% YoY) and the FY2025 annual result came in at $6000.0, changed 0.0% from the prior year.
- Other Non-Current Assets climbed to $90000.0 in Q1 2026, from $6000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $8.0 million in Q3 2025 and troughed at $6000.0 in Q3 2022.
- A 5-year average of $492588.2 and a median of $6000.0 in 2022 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets slumped 86.96% — and 2025, when it jumped 133700.0%.
- Tracing ENTX's Other Non-Current Assets over 5 years: stood at $6000.0 in 2022, then changed by 0.0% to $6000.0 in 2023, then changed by 0.0% to $6000.0 in 2024, then changed by 0.0% to $6000.0 in 2025, then jumped by 1400.0% to $90000.0 in 2026.
- Business Quant data shows ENTX's Other Non-Current Assets at $90000.0 in Q1 2026, $6000.0 in Q4 2025, and $8.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Entera Bio | 57.79 Mn | 53.65 Mn | - | 90,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 90,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Sep 30, 2025 | 8.03 Mn |
| Jun 30, 2025 | 6,000.00 |
| Mar 31, 2025 | 92,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Sep 30, 2024 | 6,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Dec 31, 2023 | 6,000.00 |
| Sep 30, 2023 | 6,000.00 |
| Jun 30, 2023 | 6,000.00 |
| Mar 31, 2023 | 6,000.00 |
| Dec 31, 2022 | 6,000.00 |
| Sep 30, 2022 | 6,000.00 |
| Jun 30, 2022 | 46,000.00 |
| Mar 31, 2022 | 46,000.00 |
| Dec 31, 2021 | 46,000.00 |
| Dec 31, 2020 | 47,000.00 |